HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

YM 435

structure given in first source
Also Known As:
(-)-(S)-4-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 7,8-DDPTI; 7,8-dihydroxy-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline; YM-435; YM435; zelandopam
Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yatsu, Takeyuki: 2 articles (03/2005 - 02/2003)
2. Aoki, Motonori: 2 articles (03/2005 - 02/2003)
3. Tanaka, Akihiro: 1 article (03/2005)
4. Inagaki, Osamu: 1 article (02/2003)

Related Diseases

1. Nephrosis
2. Acute Kidney Injury (Acute Renal Failure)
3. Atherosclerosis
4. Hypertrophy
5. Proteinuria

Related Drugs and Biologics

1. Dopamine (Intropin)
2. Platelet-Derived Growth Factor
3. platelet-derived growth factor BB (becaplermin)
4. 2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)
5. Dopamine D1 Receptors (Dopamine D1 Receptor)
6. Sodium
7. Puromycin Aminonucleoside
8. Prednisolone (Predate)
9. Cisplatin (Platino)
10. Cholesterol

Related Therapies and Procedures

1. Intravenous Infusions
2. Intravenous Injections